investorscraft@gmail.com

Investing in Certara, Inc. (CERT)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)2.76-77
Intrinsic value (DCF)4.60-62
Graham-Dodd Method0.00-100
Graham Formula1.08-91

Company description

Certara is a leading provider of software and scientific consulting services for drug development and regulatory decision making. With their strong scientific expertise and cutting-edge technology, they are committed to helping biopharmaceutical companies navigate the complex world of drug development. Their comprehensive solutions cover all stages of the drug development process, from pre-clinical research to post-market surveillance. Certara's innovative products and services have been used by over 1,600 biopharma companies and regulatory agencies worldwide, resulting in more than 90 percent of drugs approved by the FDA using their software. The company also offers personalized consulting services, ensuring that their clients receive tailored solutions to address their specific needs. Certara prides itself on their collaborative approach, working closely with clients to accelerate the development of safe, effective, and innovative medicines. With their strong track record and commitment to excellence, Certara continues to be a trusted partner to the biopharma industry, paving the way for improved patient outcomes and better healthcare.
HomeMenuAccount